Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of a Complex Inflammatory Milieu Induced by BCG Treatment in Urines of Patients With Non-muscle-invasive Bladder Cancer on the Xpert® Bladder Cancer Assay

NCT02895620 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT02895620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02895620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of a Complex Inflammatory Milieu Induced by BCG Treatment in Urines of Patients With Non-muscle-invasive Bladder Cancer on the Xpert® Bladder Cancer Assay
Lead sponsor
Institut Claudius Regaud
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2016
Completion date
August 31, 2017
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non muscle invasive bladder cancer, treatment by bcg